BioVectra: Funding, Investors & Team (Sep 2026)
BioVectra manufactures ingredients for global pharmaceutical and biotechnology clients offering therapeutics used in the treatment of cancer, kidney disease, cardio-vascular disease, multiple sclerosis, and many other serious diseases. With over 40 years experience, the company is proficient in synthetic organic chemistry, fermentation of chemical and biologic molecules, downstream processing, MPEG production, and conjugation chemistry. BioVectra was founded on 1970 and is based in Charlottetown, Canada.
BioVectra has raised $39.8M across 1 funding round on record, the most recent a Grant of $39.8M announced in Nov 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BioVectra Company Profile and Key Stats
Latest funding round on record: Nov 2021.
BioVectra Funding Rounds
BioVectra Founders and Leadership Team
No contact details are on record for this team yet.
BioVectra Funding Compared to Other Biotechnology Startups
BioVectra's latest round of $39.8M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BioVectra in Biotechnology and Charlottetown
Companies Similar to BioVectra
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
BioVectra Funding FAQs
What does BioVectra do?
BioVectra manufactures ingredients for global pharmaceutical and biotechnology clients offering therapeutics used in the treatment of cancer, kidney disease, cardio-vascular disease, multiple sclerosis, and many other serious diseases. With over 40 years experience, the company is proficient in synthetic organic chemistry, fermentation of chemical and biologic molecules, downstream processing, MPEG production, and conjugation chemistry. BioVectra was founded on 1970 and is based in Charlottetown, Canada.
How much funding has BioVectra raised?
BioVectra has raised $39.8M across 1 round on record. The most recent is a Grant of $39.8M announced in Nov 2021.
When did BioVectra last raise funding?
BioVectra's most recent funding round on record is a Grant of $39.8M, announced in Nov 2021.
Who is the CEO of BioVectra?
Ron Keefe is listed as CEO at BioVectra.
Where is BioVectra headquartered?
BioVectra is based in Charlottetown, Prince Edward Island, Canada.
How many employees does BioVectra have?
BioVectra is in the 251-500 employee band.
How does BioVectra's funding compare to other Biotechnology startups?
BioVectra's latest round of $39.8M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's BioVectra Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BioVectra is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.